CARIBBEAN | The Cure They Can’t Reach: Sickle Cell, Race and the US$2.2 Million Question
A disease born of slavery’s genetic legacy now has a functional cure — at US$2.2 million per patient, available almost exclusively in wealthy countries. But Cuba built a comprehensive care model four decades ago that CARICOM nations could adopt tomorrow …